Stocks and Investing Stocks and Investing
Mon, July 22, 2024

Tycho Peterson Upgraded (TXG) to Strong Buy and Held Target at $24 on, Jul 22nd, 2024


Published on 2024-10-28 12:38:15 - WOPRAI, Tycho Peterson
  Print publication without navigation


Tycho Peterson of Jefferies, Upgraded "10x Genomics, Inc." (TXG) to Strong Buy and Held Target at $24 on, Jul 22nd, 2024.

Tycho has made no other calls on TXG in the last 4 months.



There are 11 other peers that have a rating on TXG. Out of the 11 peers that are also analyzing TXG, 7 agree with Tycho's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derik De Bruin of "B of A Securities" Maintained at Hold with Decreased Target to $25 on, Thursday, July 18th, 2024
  • Rachel Vatnsdal of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $20 on, Thursday, July 18th, 2024
  • Justin Bowers of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Wednesday, July 10th, 2024
  • Doug Schenkel of "Wolfe Research" Downgraded from Buy to Hold on, Thursday, June 27th, 2024
  • Subbu Nambi of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, June 26th, 2024
  • Dan Brennan of "TD Cowen" Downgraded from Strong Buy to Hold and Decreased Target to $32 on, Wednesday, May 1st, 2024
  • Dan Leonard of "UBS" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 1st, 2024


These are the ratings of the 4 analyists that currently disagree with Tycho


  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, July 16th, 2024
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $16 on, Tuesday, July 9th, 2024
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $24 on, Friday, June 28th, 2024
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Monday, April 29th, 2024

Contributing Sources